nodes	percent_of_prediction	percent_of_DWPC	metapath
Droperidol—Consciousness abnormal—Vincristine—sarcoma	0.124	0.126	CcSEcCtD
Droperidol—Altered state of consciousness—Vincristine—sarcoma	0.0465	0.0474	CcSEcCtD
Droperidol—Sudden death—Mitoxantrone—sarcoma	0.0409	0.0416	CcSEcCtD
Droperidol—Inappropriate antidiuretic hormone secretion—Vincristine—sarcoma	0.037	0.0376	CcSEcCtD
Droperidol—Extrapyramidal disorder—Thiotepa—sarcoma	0.0322	0.0328	CcSEcCtD
Droperidol—Amenorrhoea—Thiotepa—sarcoma	0.0276	0.0281	CcSEcCtD
Droperidol—Amenorrhoea—Mitoxantrone—sarcoma	0.0238	0.0242	CcSEcCtD
Droperidol—Laryngospasm—Etoposide—sarcoma	0.0233	0.0237	CcSEcCtD
Droperidol—Cardiac arrest—Thiotepa—sarcoma	0.0167	0.017	CcSEcCtD
Droperidol—Cardiac arrest—Vincristine—sarcoma	0.0148	0.0151	CcSEcCtD
Droperidol—Hyperglycaemia—Thiotepa—sarcoma	0.0137	0.014	CcSEcCtD
Droperidol—Ventricular arrhythmia—Epirubicin—sarcoma	0.0132	0.0134	CcSEcCtD
Droperidol—Ventricular arrhythmia—Doxorubicin—sarcoma	0.0122	0.0124	CcSEcCtD
Droperidol—Hallucination—Thiotepa—sarcoma	0.0121	0.0123	CcSEcCtD
Droperidol—Cardiac arrest—Etoposide—sarcoma	0.012	0.0122	CcSEcCtD
Droperidol—Depression—Vincristine—sarcoma	0.012	0.0122	CcSEcCtD
Droperidol—Hyperglycaemia—Mitoxantrone—sarcoma	0.0118	0.0121	CcSEcCtD
Droperidol—Drowsiness—Mitoxantrone—sarcoma	0.0117	0.0119	CcSEcCtD
Droperidol—Amenorrhoea—Epirubicin—sarcoma	0.0111	0.0113	CcSEcCtD
Droperidol—Chills—Thiotepa—sarcoma	0.0109	0.0111	CcSEcCtD
Droperidol—Chills—Dactinomycin—sarcoma	0.0108	0.011	CcSEcCtD
Droperidol—Bronchospasm—Etoposide—sarcoma	0.0107	0.0109	CcSEcCtD
Droperidol—Hallucination—Vincristine—sarcoma	0.0107	0.0109	CcSEcCtD
Droperidol—Amenorrhoea—Doxorubicin—sarcoma	0.0103	0.0105	CcSEcCtD
Droperidol—Ventricular tachycardia—Epirubicin—sarcoma	0.00976	0.00993	CcSEcCtD
Droperidol—Chills—Mitoxantrone—sarcoma	0.00943	0.0096	CcSEcCtD
Droperidol—Hypertension—Thiotepa—sarcoma	0.00915	0.00931	CcSEcCtD
Droperidol—Ventricular tachycardia—Doxorubicin—sarcoma	0.00903	0.00919	CcSEcCtD
Droperidol—Anxiety—Thiotepa—sarcoma	0.00899	0.00915	CcSEcCtD
Droperidol—Tachycardia—Thiotepa—sarcoma	0.00844	0.00859	CcSEcCtD
Droperidol—Hypertension—Vincristine—sarcoma	0.00811	0.00826	CcSEcCtD
Droperidol—Hypertension—Mitoxantrone—sarcoma	0.0079	0.00804	CcSEcCtD
Droperidol—Chills—Etoposide—sarcoma	0.00784	0.00798	CcSEcCtD
Droperidol—Anxiety—Mitoxantrone—sarcoma	0.00776	0.0079	CcSEcCtD
Droperidol—Somnolence—Thiotepa—sarcoma	0.00769	0.00782	CcSEcCtD
Droperidol—Anaphylactic shock—Vincristine—sarcoma	0.00767	0.0078	CcSEcCtD
Droperidol—Anaphylactic shock—Mitoxantrone—sarcoma	0.00747	0.0076	CcSEcCtD
Droperidol—Shock—Mitoxantrone—sarcoma	0.00735	0.00748	CcSEcCtD
Droperidol—Tachycardia—Mitoxantrone—sarcoma	0.00729	0.00742	CcSEcCtD
Droperidol—Hypotension—Vincristine—sarcoma	0.00716	0.00729	CcSEcCtD
Droperidol—Hypotension—Mitoxantrone—sarcoma	0.00698	0.0071	CcSEcCtD
Droperidol—Body temperature increased—Thiotepa—sarcoma	0.00684	0.00696	CcSEcCtD
Droperidol—Body temperature increased—Dactinomycin—sarcoma	0.00678	0.00691	CcSEcCtD
Droperidol—Cardiac arrest—Epirubicin—sarcoma	0.00674	0.00686	CcSEcCtD
Droperidol—Loss of consciousness—Etoposide—sarcoma	0.00669	0.00681	CcSEcCtD
Droperidol—Somnolence—Mitoxantrone—sarcoma	0.00664	0.00676	CcSEcCtD
Droperidol—Hypertension—Etoposide—sarcoma	0.00657	0.00669	CcSEcCtD
Droperidol—Hypersensitivity—Thiotepa—sarcoma	0.00637	0.00648	CcSEcCtD
Droperidol—Hypersensitivity—Dactinomycin—sarcoma	0.00632	0.00644	CcSEcCtD
Droperidol—Cardiac arrest—Doxorubicin—sarcoma	0.00623	0.00634	CcSEcCtD
Droperidol—Anaphylactic shock—Etoposide—sarcoma	0.00621	0.00632	CcSEcCtD
Droperidol—Tachycardia—Etoposide—sarcoma	0.00606	0.00617	CcSEcCtD
Droperidol—Body temperature increased—Vincristine—sarcoma	0.00606	0.00617	CcSEcCtD
Droperidol—Body temperature increased—Mitoxantrone—sarcoma	0.0059	0.00601	CcSEcCtD
Droperidol—Hypotension—Etoposide—sarcoma	0.0058	0.00591	CcSEcCtD
Droperidol—Dizziness—Thiotepa—sarcoma	0.00572	0.00582	CcSEcCtD
Droperidol—Hypersensitivity—Vincristine—sarcoma	0.00565	0.00575	CcSEcCtD
Droperidol—Hyperglycaemia—Epirubicin—sarcoma	0.00552	0.00562	CcSEcCtD
Droperidol—Somnolence—Etoposide—sarcoma	0.00552	0.00562	CcSEcCtD
Droperidol—Hypersensitivity—Mitoxantrone—sarcoma	0.0055	0.0056	CcSEcCtD
Droperidol—Drowsiness—Epirubicin—sarcoma	0.00546	0.00556	CcSEcCtD
Droperidol—Rash—Thiotepa—sarcoma	0.00545	0.00555	CcSEcCtD
Droperidol—Dermatitis—Thiotepa—sarcoma	0.00545	0.00554	CcSEcCtD
Droperidol—Rash—Dactinomycin—sarcoma	0.00541	0.00551	CcSEcCtD
Droperidol—Hyperglycaemia—Doxorubicin—sarcoma	0.00511	0.0052	CcSEcCtD
Droperidol—Dizziness—Vincristine—sarcoma	0.00507	0.00516	CcSEcCtD
Droperidol—Drowsiness—Doxorubicin—sarcoma	0.00505	0.00514	CcSEcCtD
Droperidol—Body temperature increased—Etoposide—sarcoma	0.00491	0.005	CcSEcCtD
Droperidol—Rash—Vincristine—sarcoma	0.00483	0.00492	CcSEcCtD
Droperidol—Dermatitis—Vincristine—sarcoma	0.00483	0.00492	CcSEcCtD
Droperidol—Rash—Mitoxantrone—sarcoma	0.00471	0.00479	CcSEcCtD
Droperidol—Dermatitis—Mitoxantrone—sarcoma	0.0047	0.00479	CcSEcCtD
Droperidol—Hypersensitivity—Etoposide—sarcoma	0.00458	0.00466	CcSEcCtD
Droperidol—Chills—Epirubicin—sarcoma	0.0044	0.00448	CcSEcCtD
Droperidol—Dizziness—Etoposide—sarcoma	0.00411	0.00418	CcSEcCtD
Droperidol—Chills—Doxorubicin—sarcoma	0.00407	0.00414	CcSEcCtD
Droperidol—Rash—Etoposide—sarcoma	0.00392	0.00399	CcSEcCtD
Droperidol—Dermatitis—Etoposide—sarcoma	0.00391	0.00398	CcSEcCtD
Droperidol—Syncope—Epirubicin—sarcoma	0.00383	0.00389	CcSEcCtD
Droperidol—Palpitations—Epirubicin—sarcoma	0.00377	0.00384	CcSEcCtD
Droperidol—Loss of consciousness—Epirubicin—sarcoma	0.00375	0.00382	CcSEcCtD
Droperidol—Hypertension—Epirubicin—sarcoma	0.00368	0.00375	CcSEcCtD
Droperidol—Anxiety—Epirubicin—sarcoma	0.00362	0.00368	CcSEcCtD
Droperidol—Syncope—Doxorubicin—sarcoma	0.00354	0.0036	CcSEcCtD
Droperidol—Palpitations—Doxorubicin—sarcoma	0.00349	0.00355	CcSEcCtD
Droperidol—Anaphylactic shock—Epirubicin—sarcoma	0.00348	0.00354	CcSEcCtD
Droperidol—Loss of consciousness—Doxorubicin—sarcoma	0.00347	0.00353	CcSEcCtD
Droperidol—Shock—Epirubicin—sarcoma	0.00343	0.00349	CcSEcCtD
Droperidol—Hypertension—Doxorubicin—sarcoma	0.00341	0.00347	CcSEcCtD
Droperidol—Tachycardia—Epirubicin—sarcoma	0.0034	0.00346	CcSEcCtD
Droperidol—Anxiety—Doxorubicin—sarcoma	0.00335	0.00341	CcSEcCtD
Droperidol—Hypotension—Epirubicin—sarcoma	0.00325	0.00331	CcSEcCtD
Droperidol—HTR2A—pulmonary artery—sarcoma	0.00324	0.184	CbGeAlD
Droperidol—Anaphylactic shock—Doxorubicin—sarcoma	0.00322	0.00328	CcSEcCtD
Droperidol—Shock—Doxorubicin—sarcoma	0.00317	0.00323	CcSEcCtD
Droperidol—Tachycardia—Doxorubicin—sarcoma	0.00314	0.0032	CcSEcCtD
Droperidol—Somnolence—Epirubicin—sarcoma	0.0031	0.00315	CcSEcCtD
Droperidol—Hypotension—Doxorubicin—sarcoma	0.00301	0.00306	CcSEcCtD
Droperidol—Somnolence—Doxorubicin—sarcoma	0.00286	0.00292	CcSEcCtD
Droperidol—Body temperature increased—Epirubicin—sarcoma	0.00275	0.0028	CcSEcCtD
Droperidol—Hypersensitivity—Epirubicin—sarcoma	0.00257	0.00261	CcSEcCtD
Droperidol—Body temperature increased—Doxorubicin—sarcoma	0.00255	0.00259	CcSEcCtD
Droperidol—Hypersensitivity—Doxorubicin—sarcoma	0.00237	0.00242	CcSEcCtD
Droperidol—Dizziness—Epirubicin—sarcoma	0.0023	0.00234	CcSEcCtD
Droperidol—Rash—Epirubicin—sarcoma	0.0022	0.00223	CcSEcCtD
Droperidol—Dermatitis—Epirubicin—sarcoma	0.00219	0.00223	CcSEcCtD
Droperidol—Dizziness—Doxorubicin—sarcoma	0.00213	0.00217	CcSEcCtD
Droperidol—Rash—Doxorubicin—sarcoma	0.00203	0.00207	CcSEcCtD
Droperidol—Dermatitis—Doxorubicin—sarcoma	0.00203	0.00207	CcSEcCtD
Droperidol—HTR2A—hindlimb—sarcoma	0.00196	0.112	CbGeAlD
Droperidol—HTR2A—appendage—sarcoma	0.00168	0.0957	CbGeAlD
Droperidol—HTR2A—endothelium—sarcoma	0.00102	0.0578	CbGeAlD
Droperidol—KCNH2—myometrium—sarcoma	0.000868	0.0494	CbGeAlD
Droperidol—KCNH2—seminal vesicle—sarcoma	0.000784	0.0446	CbGeAlD
Droperidol—ADRA1A—hematopoietic system—sarcoma	0.000771	0.0439	CbGeAlD
Droperidol—KCNH2—hematopoietic system—sarcoma	0.000745	0.0424	CbGeAlD
Droperidol—KCNH2—cardiac atrium—sarcoma	0.000566	0.0322	CbGeAlD
Droperidol—KCNH2—uterus—sarcoma	0.000563	0.032	CbGeAlD
Droperidol—HTR2A—embryo—sarcoma	0.000559	0.0318	CbGeAlD
Droperidol—ADRA1A—lymphoid tissue—sarcoma	0.000543	0.0309	CbGeAlD
Droperidol—HTR2A—hematopoietic system—sarcoma	0.000499	0.0284	CbGeAlD
Droperidol—HTR2A—connective tissue—sarcoma	0.00048	0.0273	CbGeAlD
Droperidol—KCNH2—bone marrow—sarcoma	0.000478	0.0272	CbGeAlD
Droperidol—HTR2A—smooth muscle tissue—sarcoma	0.000439	0.025	CbGeAlD
Droperidol—DRD2—testis—sarcoma	0.000414	0.0236	CbGeAlD
Droperidol—KCNH2—testis—sarcoma	0.000408	0.0232	CbGeAlD
Droperidol—ADRA1A—liver—sarcoma	0.0004	0.0227	CbGeAlD
Droperidol—HTR2A—tendon—sarcoma	0.00033	0.0188	CbGeAlD
Droperidol—KCNH2—lymph node—sarcoma	0.000296	0.0168	CbGeAlD
Droperidol—HTR2A—testis—sarcoma	0.000273	0.0155	CbGeAlD
Droperidol—HTR2A—liver—sarcoma	0.000258	0.0147	CbGeAlD
